advertisement

Topcon

Purinergic signalling 8

Showing records 1 to 8 | Display all abstracts in Purinergic signalling

78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Pérez de Lara MJ
Purinergic signalling 2018; 14: 259-270
78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Jacob TF; Singh V
Purinergic signalling 2018; 14: 271-284
78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Guzmán-Aranguez A; Gómez-Villafuertes R
Purinergic signalling 2018; 14: 259-270
78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Dixit M; Ginsburg-Shmuel T
Purinergic signalling 2018; 14: 271-284
78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Gualix J
Purinergic signalling 2018; 14: 259-270
78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Fonseca B
Purinergic signalling 2018; 14: 271-284
78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Miras-Portugal MT; Pintor J
Purinergic signalling 2018; 14: 259-270
78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Pintor J; Youdim MBH; Major DT; Weinreb O; Fischer B
Purinergic signalling 2018; 14: 271-284

Issue 19-4

Change Issue


advertisement

WGA Rescources